Emergent BioSolutions Inc. — Director's Dealing 2020

May 29, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2020-05-21

Reporting Person: Smith Karen L. (EVP, Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6310	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Options (Right to Buy)	$79.25	2027-05-07	Common Stock (12619.0)		Direct

Footnotes

F1: Consists of 3,155 unvested PSUs and 3,155 unvested RSUs granted from the Emergent Stock Incentive Plan. Each RSU and each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of GAAP revenue on a cumulative basis over the three-year period beginning on January 1, 2020 and ending on December 31, 2022, as certified by the Compensation Committee following the performance period. The RSUs vest annually in three equal installments beginning on the day prior to the anniversary date of the grant, or 05/07/2020.

F2: Vests in three equal installments beginning on the day prior to the anniversary date of the grant, or 05/07/2020.